One shot of AstraZeneca vaccine reduces death risk by 80%, shows new data


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
AstraZeneca vaccine efficacy documented successfully

Data from the rollout of AstraZeneca's Covid-19 vaccine shows one dose of the shot results in 80% less risk of death from the disease, Public Health England said on Monday.


One dose of the AstraZeneca vaccine can reduce death risk by 80%, says new data. Data from the rollout of AstraZeneca's Covid-19 vaccine shows one dose of the shot results in 80% less risk of death from the disease, Public Health England said on Monday.

It also said protection against death from the Pfizer-BioNTech vaccine rises from approximately 80% after one dose to 97% after two doses in its new analysis.


PHE said the study was the first on protection against mortality from the AstraZeneca vaccine based on data from a real world setting.

The study looked at new symptomatic cases of Covid-19 between December and April and people who died within 28 days of their positive test by vaccination status.

People who had a single dose of AstraZeneca vaccine were 55% protected against death, with a figure of 44% protection for a single dose of Pfizer, compared to unvaccinated people.

"Combined with the protection vaccines offer against becoming a case in the first place, this is equivalent to approximately 80% protection against mortality in individuals vaccinated with a single dose of either vaccine," PHE said in a statement.

Protection against mortality from the Pfizer-BioNTech vaccine improved to 69% for cases who had their second dose at least a week before they tested positive. Combined with the estimated protection from getting Covid-19 to start with, this is equivalent to an estimated 97% protection, PHE said.

Prime Minister Boris Johnson is set to confirm the further easing of lockdown restrictions in England on Monday, helped in part by the speed of the country's vaccine rollout.

In another dataset, PHE said that it was estimated that two doses of the Pfizer-BioNTech vaccine reduce the risk of hospitalization by 93% for the over 80s.

Tags : #AstraZeneca #PfizerVaccine #AstraZenecaVaccine #BorisJohnson

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026